Total Payments
$900,009
2024 Payments
$70,949
Companies
18
Transactions
934
Medicare Patients
1,629
Medicare Billing
$143,272
Payment Breakdown by Category
Other$804,145 (89.3%)
Consulting$51,177 (5.7%)
Travel$25,453 (2.8%)
Food & Beverage$19,020 (2.1%)
Education$213.05 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $801,913 | 307 | 89.1% |
| Consulting Fee | $51,177 | 19 | 5.7% |
| Travel and Lodging | $25,453 | 257 | 2.8% |
| Food and Beverage | $19,020 | 345 | 2.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,232 | 1 | 0.2% |
| Education | $213.05 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $392,196 | 374 | $0 (2024) |
| EMD Serono, Inc. | $159,699 | 157 | $0 (2024) |
| Biogen, Inc. | $104,588 | 127 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $70,866 | 90 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $52,807 | 45 | $0 (2024) |
| Genentech USA, Inc. | $31,290 | 28 | $0 (2019) |
| Celgene Corporation | $30,690 | 46 | $0 (2024) |
| TG Therapeutics, Inc. | $17,910 | 11 | $0 (2024) |
| Mallinckrodt LLC | $14,010 | 18 | $0 (2017) |
| Acorda Therapeutics, Inc | $11,662 | 16 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $70,949 | 52 | EMD Serono, Inc. ($30,094) |
| 2023 | $57,661 | 52 | EMD Serono, Inc. ($40,825) |
| 2022 | $91,496 | 97 | EMD Serono, Inc. ($38,942) |
| 2020 | $64,548 | 86 | Celgene Corporation ($21,528) |
| 2019 | $172,887 | 194 | GENZYME CORPORATION ($72,135) |
| 2018 | $203,668 | 201 | GENZYME CORPORATION ($148,155) |
| 2017 | $238,800 | 252 | GENZYME CORPORATION ($166,948) |
All Payment Transactions
934 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,025.00 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Neurology | ||||||
| 12/11/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Immunology | ||||||
| 12/11/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: Immunology | ||||||
| 12/06/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $12.59 | General |
| 12/02/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,273.00 | General |
| Category: Neurology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $124.74 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $930.00 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Biogen, Inc. | VUMERITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,961.00 | General |
| Category: Neurology | ||||||
| 10/10/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $83.83 | General |
| Category: Neurology | ||||||
| 10/02/2024 | Biogen, Inc. | VUMERITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,269.00 | General |
| Category: Neurology | ||||||
| 09/13/2024 | Biogen, Inc. | VUMERITY (Drug) | Consulting Fee | Cash or cash equivalent | $423.00 | General |
| Category: Neurology | ||||||
| 08/20/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,107.50 | General |
| Category: Immunology | ||||||
| 08/20/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Travel and Lodging | Cash or cash equivalent | $20.10 | General |
| Category: Immunology | ||||||
| 08/09/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,463.00 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Biogen, Inc. | VUMERITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,961.00 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Biogen, Inc. | VUMERITY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,115.00 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Biogen, Inc. | VUMERITY (Drug) | Travel and Lodging | Cash or cash equivalent | $140.00 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $47.48 | General |
| Category: Neurology | ||||||
| 07/19/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,934.00 | General |
| Category: Neurology | ||||||
| 07/16/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $25.60 | General |
| 06/20/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,107.50 | General |
| Category: Immunology | ||||||
| 06/18/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,025.00 | General |
| Category: Neuroscience | ||||||
| 06/17/2024 | Biogen, Inc. | TYSABRI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,269.00 | General |
| Category: Neurology | ||||||
| 06/06/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $124.74 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 344 | 380 | $84,820 | $28,046 |
| 2022 | 10 | 381 | 409 | $97,020 | $33,408 |
| 2021 | 12 | 444 | 480 | $114,110 | $40,556 |
| 2020 | 11 | 460 | 500 | $120,310 | $41,261 |
Total Patients
1,629
Total Services
1,769
Medicare Billing
$143,272
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 106 | 108 | $29,425 | $10,385 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 66 | 74 | $15,665 | $4,912 | 31.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 70 | $12,100 | $4,267 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 35 | 35 | $11,095 | $3,257 | 29.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,050 | $1,640 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 21 | $4,395 | $1,554 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 26 | 26 | $3,960 | $1,133 | 28.6% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Office | 2023 | 19 | 19 | $1,425 | $471.41 | 33.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 11 | $1,705 | $427.24 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 51 | 51 | $16,065 | $4,904 | 30.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 35 | $9,275 | $3,614 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 56 | 59 | $12,095 | $3,592 | 29.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 47 | 47 | $9,165 | $3,587 | 39.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 37 | 52 | $8,840 | $2,739 | 31.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $6,630 | $2,666 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 33 | $6,765 | $2,645 | 39.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 33 | $6,600 | $2,411 | 36.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 15 | 15 | $5,850 | $2,209 | 37.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 15 | 16 | $4,400 | $1,738 | 39.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $5,935 | $1,618 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 24 | 24 | $3,360 | $1,081 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $2,040 | $604.45 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 79 | 88 | $18,040 | $5,991 | 33.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 29 | 29 | $11,310 | $4,618 | 40.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 40 | 53 | $10,600 | $4,353 | 41.1% |
About Dr. Gary Clauser, MD
Dr. Gary Clauser, MD is a Neurology healthcare provider based in Allentown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598773038.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Clauser, MD has received a total of $900,009 in payments from pharmaceutical and medical device companies, with $70,949 received in 2024. These payments were reported across 934 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($801,913).
As a Medicare-enrolled provider, Clauser has provided services to 1,629 Medicare beneficiaries, totaling 1,769 services with total Medicare billing of $143,272. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Allentown, PA
- Active Since 08/03/2006
- Last Updated 01/08/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1598773038
Products in Payments
- LEMTRADA (Drug) $233,356
- AUBAGIO (Drug) $157,999
- ZEPOSIA (Drug) $75,468
- Mavenclad (Drug) $75,426
- TECFIDERA (Drug) $41,743
- MAYZENT (Drug) $33,402
- MAVENCLAD (Drug) $31,715
- GILENYA (Drug) $29,927
- OCREVUS (Biological) $26,168
- VUMERITY (Drug) $23,738
- Rebif (Biological) $21,868
- TYSABRI (Biological) $21,552
- BRIUMVI (Drug) $17,910
- Mavenclad (Biological) $15,207
- ACTHAR (Biological) $14,042
- AMPYRA (Drug) $11,662
- Evobrutinib $8,400
- Ozanimod (Drug) $6,829
- UBRELVY (Drug) $5,618
- Non-Covered Product (Drug) $5,121
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Allentown
Dr. Behrang Saminejad, M.d, M.D
Neurology — Payments: $417,790
Neurology $417,790
Dr. Christopher Wohlberg, Md, Phd, MD, PHD
Neurology — Payments: $357,715
Neurology $357,715
Steven Lovitt, M.d, M.D
Neurology — Payments: $230,765
Neurology $230,765
Dr. Vitaliy Koss, M.d, M.D
Neurology — Payments: $224,701
Neurology $224,701
Megan Leary, M.d, M.D
Neurology — Payments: $120,603
Neurology $120,603
Jian Chen, M.d.,Ph.d, M.D.,PH.D
Neurology — Payments: $3,423
Neurology $3,423